1
/
of
1
Elabscience
SKU:PKSV030324
Recombinant SARS-CoV-2 S+E+M protein
Recombinant SARS-CoV-2 S+E+M protein
Regular price
$493.00 USD
Regular price
Sale price
$493.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
The Recombinant SARS-CoV-2 S+E+M Protein is a cutting-edge product designed to aid in the research and development of diagnostics, vaccines, and therapeutics for the novel coronavirus, SARS-CoV-2. This protein is a recombinant fusion of the Spike (S), Envelope (E), and Membrane (M) proteins of the virus, which are crucial for viral entry, replication, and immune response.
Produced using advanced biotechnological techniques, this recombinant protein offers high purity, stability, and functionality, making it an ideal tool for various applications. The S protein, responsible for viral attachment and fusion with host cells, is of particular interest due to its role in viral entry and its potential as a target for neutralizing antibodies. The E protein plays a vital role in viral assembly and release, while the M protein is involved in viral structure and immune evasion. By combining these three essential proteins, researchers can gain a comprehensive understanding of the virus and develop effective countermeasures.
The Recombinant SARS-CoV-2 S+E+M Protein is rigorously quality-controlled to ensure its suitability for research purposes. It is produced in a state-of-the-art facility under strict cGMP guidelines, guaranteeing batch-to-batch consistency and reproducibility. This protein is available in various formats, including lyophilized powder or liquid, to accommodate different experimental requirements. Furthermore, it can be easily reconstituted and used in a wide range of applications, such as ELISA, Western blotting, protein-protein interaction studies, and vaccine development.
In summary, the Recombinant SARS-CoV-2 S+E+M Protein is a highly reliable and versatile tool for scientists and researchers working towards understanding the SARS-CoV-2 virus and developing effective diagnostics, vaccines, and therapeutics. With its exceptional purity, stability, and functionality, this protein enables comprehensive investigations into viral entry, replication, and immune response. By utilizing this cutting-edge product, researchers can contribute to the global efforts in combating the COVID-19 pandemic.
Produced using advanced biotechnological techniques, this recombinant protein offers high purity, stability, and functionality, making it an ideal tool for various applications. The S protein, responsible for viral attachment and fusion with host cells, is of particular interest due to its role in viral entry and its potential as a target for neutralizing antibodies. The E protein plays a vital role in viral assembly and release, while the M protein is involved in viral structure and immune evasion. By combining these three essential proteins, researchers can gain a comprehensive understanding of the virus and develop effective countermeasures.
The Recombinant SARS-CoV-2 S+E+M Protein is rigorously quality-controlled to ensure its suitability for research purposes. It is produced in a state-of-the-art facility under strict cGMP guidelines, guaranteeing batch-to-batch consistency and reproducibility. This protein is available in various formats, including lyophilized powder or liquid, to accommodate different experimental requirements. Furthermore, it can be easily reconstituted and used in a wide range of applications, such as ELISA, Western blotting, protein-protein interaction studies, and vaccine development.
In summary, the Recombinant SARS-CoV-2 S+E+M Protein is a highly reliable and versatile tool for scientists and researchers working towards understanding the SARS-CoV-2 virus and developing effective diagnostics, vaccines, and therapeutics. With its exceptional purity, stability, and functionality, this protein enables comprehensive investigations into viral entry, replication, and immune response. By utilizing this cutting-edge product, researchers can contribute to the global efforts in combating the COVID-19 pandemic.
Share
